CYCLERION THERAPEUTICS, INC. Lessee, Operating Lease, Discount Rate
CYCLERION THERAPEUTICS, INC. (CYCN) had Lessee, Operating Lease, Discount Rate of 10.90% as of 2019-04-01, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseDiscountRate · last filed 2019-11-12
- 2019-04-01: Lessee, Operating Lease, Discount Rate 10.90%.
| Period end | Lessee, Operating Lease, Discount Rate |
|---|---|
| 2019-04-01 | 10.90% 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |